Member Article

Tomorrows Medicine secures £250,000 North West investment

Cheshire-based clinical trial recruiter, Tomorrows Medicines Ltd, has raised an investment of over £250,000 from a group of investors.

The company has developed a web platform that allows patients who want to be involved in medical testing to join and find clinical trials local to them.

Based at Daresbury Sci-Tech park, the firm won £100,500 from The North West Fund for Biomedical, managed by SPARK Impact, £100,500 from private investors and £50,000 from the Technology Strategy Board.

Dr Clare Nolan, chief executive of Tomorrows Medicines, said: “We are delighted to receive the funding from the three parties and to receive recognition that the company provides an important service offering.

“It will enable us to provide a fully-supported service to global pharmaceutical, biotech and diagnostic companies looking to accelerate patient recruitment across all clinical areas.

“The clinical trial recruitment process is critical for the discovery of much-needed medical treatments and we can now make this process simpler, faster and more accessible.”

Tomorrows Medicines also serves global pharmaceutical, biotech, diagnostic, academic and other research organisation study teams in recruiting trial participants.

Funding raised by the firm will be used to commercialise its services and online platform, YourTreatmentChoices.com, following successes with patients being linked to clinical trials in 78 countries.

Dr Penny Attridge, senior investment director at SPARK Impact and manager of The North West Fund for Biomedical, commented: “From day one we could see the potential in Tomorrows Medicines’ novel, interactive platform for patient recruitment and retention services.

“Clinical research offers exciting drug discovery opportunities and we hope the investments will make a real difference to continue to grow the company.”

This investment marks The North West Fund for Biomedical’s 60th investment to date, and the 40th business to secure investment from the fund.

The North West Fund for Biomedical is part of the wider North West Fund, financed jointly by the European Regional Development Fund and the European Investment Bank.

This was posted in Bdaily's Members' News section by Miranda Dobson .